14-53152411-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160148.2(DDHD1):c.688G>A(p.Asp230Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160148.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDHD1 | NM_001160148.2 | c.688G>A | p.Asp230Asn | missense_variant | 1/13 | ENST00000673822.2 | NP_001153620.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDHD1 | ENST00000673822.2 | c.688G>A | p.Asp230Asn | missense_variant | 1/13 | NM_001160148.2 | ENSP00000500986.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000839 AC: 21AN: 250332Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135628
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461548Hom.: 0 Cov.: 31 AF XY: 0.000142 AC XY: 103AN XY: 727104
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74372
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.688G>A (p.D230N) alteration is located in exon 1 (coding exon 1) of the DDHD1 gene. This alteration results from a G to A substitution at nucleotide position 688, causing the aspartic acid (D) at amino acid position 230 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at